BRATTON DOUGLAS K 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:27 pm Sale | 2023-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 5,750,882 4.200% | -1,250,000 (-17.85%) | Filing |
| 2023-02-13 4:14 pm Sale | 2022-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 7,000,882 5.200% | -844,307 (-10.76%) | Filing |
| 2022-02-14 2:37 pm Sale | 2021-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 7,845,189 6.400% | -4,503,595 (-36.47%) | Filing |
| 2021-02-12 4:19 pm Sale | 2020-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 12,348,784 10.300% | -8,066,751 (-39.51%) | Filing |
| 2020-02-11 4:00 pm Sale | 2019-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 20,415,535 21.300% | -158,763 (-0.77%) | Filing |